Senescence and apoptosis in carcinogenesis of cervical squamous carcinoma

被引:39
作者
Feng, Wei
Xiao, Jianguo
Zhang, Zhihong
Rosen, Daniel G.
Brown, Robert E.
Liu, Jinsong
Duan, Xiuzhen
机构
[1] Univ Texas, Houston Med Sch, Dept Pathol, Houston, TX 77030 USA
[2] Univ Texas, Houston Med Sch, Lab Med, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
关键词
senescence; apoptosis; carcinogenesis; cervical squamous; carcinoma;
D O I
10.1038/modpathol.3800927
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Senescence and apoptosis are two key mechanisms that protect against cancer development. Many cell cycle regulators, such as p14(ARF), p15(INK4b) and p16(INK4a), are important in G1 cell cycle arrest and oncogene-induced senescence. The bcl-2 protein is one of the key components that control apoptosis, while the p53 protein plays key roles in both mechanisms. The genes of these key regulator proteins are often mutated or deleted in various malignancies. It is unknown how senescence and apoptosis are regulated in one of the most common tumors of the female genital tract, cervical squamous cell carcinoma ( SCC). In this study the, expression of senescence, apoptosis and proliferation markers in normal cervical epithelium, cervical intraepithelial neoplasia ( CIN) and SCC are characterized via immunohistochemical staining for p14ARF, p15INK4b, p16INK4a, bcl-2, p53 and Ki-67 in tissue microarray blocks containing 20 samples each of normal cervix, moderate-to-severe cervical dysplasia ( CIN II-III) and invasive SCC. Samples are derived from 60 total cases of cervical biopsies and cervical conizations. Results showed that the proliferation marker, Ki-67, is markedly increased, and the senescence markers, p15INK4b, p16INK4a and p14ARF are overexpressed in both dysplasia and carcinoma. P53 immunostain is negative in all normal cervical tissue, and positive in dysplasia and carcinoma. Although the expression of bcl-2 is increased in dysplasia, this marker is negative in approximately half of SCC cases. These results suggest that some senescence pathways are activated and are still maintained in cervical dysplasia and carcinoma. However proliferation is increased and carcinogenesis is not thwarted, leading to eventual development of cervical cancer. Other mechanisms, such as those that account for the apparent overexpression of p53 and paradoxical loss of bcl-2 expression in some SCC cases, as well as additional senescence and apoptotic pathways, may play key roles carcinogenesis of cervical SCC.
引用
收藏
页码:961 / 966
页数:6
相关论文
共 26 条
[1]   p16INK4a expression correlates with degree of cervical neoplasia:: A comparison detection of high-risk with Ki-67 expression and HPV types [J].
Agoff, SN ;
Lin, P ;
Morihara, J ;
Mao, C ;
Kiviat, NB ;
Koutsky, LA .
MODERN PATHOLOGY, 2003, 16 (07) :665-673
[2]  
Baek MJ, 2000, CANCER, V89, P60, DOI 10.1002/1097-0142(20000701)89:1<60::AID-CNCR9>3.0.CO
[3]  
2-3
[4]   Immunohistochemical staining with MIB1, bcl2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia [J].
Cameron, RI ;
Maxwell, P ;
Jenkins, D ;
McCluggage, WG .
HISTOPATHOLOGY, 2002, 41 (04) :313-321
[5]   Tumour biology -: Senescence in premalignant tumours [J].
Collado, M ;
Gil, J ;
Efeyan, A ;
Guerra, C ;
Schuhmacher, AJ ;
Barradas, M ;
Benguría, A ;
Zaballos, A ;
Flores, JM ;
Barbacid, M ;
Beach, D ;
Serrano, M .
NATURE, 2005, 436 (7051) :642-642
[6]  
Graflund M, 2004, ONCOL REP, V12, P169
[7]   Immunohistochemical expression of p53, bcl-2, and p21WAF1/CIP1 in early cervical carcinoma:: Correlation with clinical outcome [J].
Graflund, M ;
Sorbe, B ;
Karlsson, M .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2002, 12 (03) :290-298
[8]   Immunohistochemical expression of p16INK4a and bcl-2 according to HPV type and to the progression of cervical squamous intraepithelial lesions [J].
Guimaraes, MCM ;
Gonçalves, MAG ;
Soares, CP ;
Bettini, JSR ;
Duarte, RA ;
Soares, EG .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2005, 53 (04) :509-516
[9]   BCL-2 IS AN INNER MITOCHONDRIAL-MEMBRANE PROTEIN THAT BLOCKS PROGRAMMED CELL-DEATH [J].
HOCKENBERY, D ;
NUNEZ, G ;
MILLIMAN, C ;
SCHREIBER, RD ;
KORSMEYER, SJ .
NATURE, 1990, 348 (6299) :334-336
[10]  
Hockenbery D M, 1992, Semin Immunol, V4, P413